查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598833

血管閉合裝置市場：按產品、最終用戶分類 - 2025-2030 年全球預測

Vascular Closure Device Market by Product (Active Approximators, External Hemostatic Devices, Passive Approximators), End-User (Acute Care Facilities, Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，血管閉合裝置市場價值為15.9億美元，預計到2024年將達到17.1億美元，複合年成長率為7.51%，到2030年將達到26.5億美元。

血管閉合裝置市場包括設計用於在插管後密封血管開口、減少出血並加速癒合的醫療設備。這些設備對於血管造影術、血管成形術等介入性手術或需要動脈通路的手術至關重要，可促進快速止血並允許患者早期下床活動。對血管閉合裝置的需求在於它們能夠提高患者的舒適度、減少手術時間、最大限度地減少血腫等併發症，並允許患者儘早出院。典型的最終用戶包括醫院、門診手術中心和導管實驗室，其中效率和病患周轉率非常重要。

主要市場統計
基準年[2023] 15.9億美元
預測年份 [2024] 17.1億美元
預測年份 [2030] 26.5億美元
複合年成長率（%） 7.51%

心血管疾病的增加、微創手術的進步以及患者對恢復更快的手術的偏好增加推動了市場成長。此外，世界人口老化和醫療保健成本上升進一步推動了需求。開拓成本效益、環保的電器和解決新興市場未滿足的需求存在潛在的商機。可生物分解性分解封閉裝置的創新以及用於即時監控和提高有效性的智慧技術的整合也可能提供競爭優勢。

然而，市場面臨嚴格的法律規範和先進設備的高成本的限制，這可能會阻礙採用率，特別是在價格敏感地區。此外，由於這些設備需要熟練的勞動力來操作，因此也存在操作挑戰。

在創新方面，研發應著重於開發能夠改善患者治療結果同時具有環境永續的材料。智慧型設備技術有望實現即時監控並提高閉合技術的準確性。業務成長也可能來自於開拓未滲透的市場以及透過策略夥伴關係擴大分銷網路。

總體而言，血管閉合裝置市場存在巨大的商機，但解決監管、成本和營運挑戰至關重要。公司應該投資於持續的研發，以促進產品差異化，並利用技術進步來保持在這個不斷發展的市場的前沿。

市場動態：揭示快速發展的血管閉合裝置市場的關鍵市場洞察

供需的動態交互作用正在改變血管閉合裝置市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球心血管疾病盛行率不斷上升
    • 股動脈心導管檢查日益普及
    • 提高VCD成功率並縮短止血時間
  • 市場限制因素
    • 相對較高的手術成本和病人對使用橈動脈通路進行介入手術的偏好
  • 市場機會
    • 大直徑血管閉合裝置日益受到關注
    • 開發 VCD 以解決患者不適和長時間臥床等併發症
  • 市場挑戰
    • 產品召回和故障的可能性以及與 VCD 相關的風險

波特五力：駕馭血管閉合裝置市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血管閉合裝置市場的外部影響

外部宏觀環境因素在塑造血管閉合裝置市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解血管閉合器械市場的競爭狀況

血管閉合裝置市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV定位矩陣血管閉合裝置市場供應商績效評估

FPNV定位矩陣是評估血管閉合裝置市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃血管閉合裝置市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對血管閉合裝置市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球心血管疾病發生率增加
      • 股動脈心導管檢查日益普及
      • 提高VCD成功率，縮短止血時間
    • 抑制因素
      • 手術費用相對較高，患者傾向選擇以橈動脈路徑的介入性手術。
    • 機會
      • 大直徑血管閉合裝置日益受到關注
      • 開發 VCD 以解決患者不適和長時間臥床等併發症
    • 任務
      • 產品召回和故障的可能性以及 VCD 相關風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章血管閉合裝置市場：依產品

  • 主動逼近器
    • 基於夾子的設備
    • 縫合裝置
  • 外部止血裝置
  • 被動逼近器
    • 膠原蛋白塞
    • 壓縮輔助裝置
    • 密封劑或凝膠設備

第7章血管閉合裝置市場：依最終使用者分類

  • 急診設施
  • 診所
  • 醫院

第8章北美和南美血管閉合裝置市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太血管閉合裝置市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲血管閉合裝置市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Cardinal Health, Inc.
  • Cardiva Medical, Inc.
  • Cordis Corporation
  • INVAMED
  • Medtronic PLC
  • Morris Innovative, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Tricol Biomedical, Inc.
  • TZ Medical, Inc
  • Vasorum Ltd.
  • Veryan Medical Ltd
  • Vivasure Medical Ltd.
  • WL Gore & Associates
Product Code: MRR-ED54C46E8A80

The Vascular Closure Device Market was valued at USD 1.59 billion in 2023, expected to reach USD 1.71 billion in 2024, and is projected to grow at a CAGR of 7.51%, to USD 2.65 billion by 2030.

The vascular closure device market encompasses medical devices designed to seal openings in blood vessels following catheterization procedures, reducing bleeding and promoting faster healing. These devices are critical for interventional procedures like angiography, angioplasty, or procedures that require arterial access, facilitating quicker hemostasis and enabling early ambulation of patients. The necessity of vascular closure devices lies in their ability to enhance patient comfort, reduce procedure time, minimize complications such as hematoma, and enable faster discharge from medical facilities. Key end-users include hospitals, ambulatory surgical centers, and catheterization labs, where efficiency and patient turnover are critical.

KEY MARKET STATISTICS
Base Year [2023] USD 1.59 billion
Estimated Year [2024] USD 1.71 billion
Forecast Year [2030] USD 2.65 billion
CAGR (%) 7.51%

Market growth is propelled by increasing incidences of cardiovascular diseases, advancements in minimally invasive procedures, and rising patient preference for surgeries with quicker recovery times. Moreover, the aging global population and heightened healthcare expenditure further drive demand. Potential opportunities exist in developing cost-efficient, eco-friendly devices and addressing unmet needs in emerging markets. Innovations in biodegradable closure devices and integration of smart technologies for real-time monitoring and enhanced efficacy could also provide a competitive edge.

However, the market faces limitations due to stringent regulatory frameworks and the high cost of advanced devices, which could impede adoption rates, particularly in price-sensitive regions. Furthermore, the skilled labor required to operate these devices poses an operational challenge.

In terms of innovation, research should focus on developing materials that improve patient outcomes while being environmentally sustainable. Smart device technology holds promise for real-time monitoring and improved precision in closure techniques. Business growth may also come from tapping into underpenetrated markets and forming strategic partnerships to expand distribution networks.

Overall, while the vascular closure device market presents significant opportunities, addressing regulatory, cost, and operational challenges is pivotal. Companies should invest in continuous R&D to foster product differentiation and leverage technological advancements to remain at the forefront of this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Closure Device Market

The Vascular Closure Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of cardiovascular diseases globally
    • Rising popularity of femoral artery cardiac catheterization
    • Growing success rate of VCDs and short hemostasis time
  • Market Restraints
    • Relatively high cost of the procedure and patients' predilection for interventional procedures using radial artery access
  • Market Opportunities
    • Emerging concentration on large-bore vascular closure devices
    • Development of VCDs to tackle complications such as patient discomfort and prolonged bed rest
  • Market Challenges
    • Probability of product recalls and failure coupled with risks related to VCDs

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Closure Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Closure Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Closure Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Closure Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Closure Device Market

A detailed market share analysis in the Vascular Closure Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Closure Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Closure Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Closure Device Market

A strategic analysis of the Vascular Closure Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Closure Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Cardinal Health, Inc., Cardiva Medical, Inc., Cordis Corporation, INVAMED, Medtronic PLC, Morris Innovative, Inc., Teleflex Incorporated, Terumo Corporation, Tricol Biomedical, Inc., TZ Medical, Inc, Vasorum Ltd., Veryan Medical Ltd, Vivasure Medical Ltd., and W. L. Gore & Associates.

Market Segmentation & Coverage

This research report categorizes the Vascular Closure Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Active Approximators, External Hemostatic Devices, and Passive Approximators. The Active Approximators is further studied across Clip-Based Devices and Suture-Based Devices. The Passive Approximators is further studied across Collagen Plugs, Compression-Assist Devices, and Sealant- or Gel-Based Devices.
  • Based on End-User, market is studied across Acute Care Facilities, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cardiovascular diseases globally
      • 5.1.1.2. Rising popularity of femoral artery cardiac catheterization
      • 5.1.1.3. Growing success rate of VCDs and short hemostasis time
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of the procedure and patients' predilection for interventional procedures using radial artery access
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging concentration on large-bore vascular closure devices
      • 5.1.3.2. Development of VCDs to tackle complications such as patient discomfort and prolonged bed rest
    • 5.1.4. Challenges
      • 5.1.4.1. Probability of product recalls and failure coupled with risks related to VCDs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Closure Device Market, by Product

  • 6.1. Introduction
  • 6.2. Active Approximators
    • 6.2.1. Clip-Based Devices
    • 6.2.2. Suture-Based Devices
  • 6.3. External Hemostatic Devices
  • 6.4. Passive Approximators
    • 6.4.1. Collagen Plugs
    • 6.4.2. Compression-Assist Devices
    • 6.4.3. Sealant- or Gel-Based Devices

7. Vascular Closure Device Market, by End-User

  • 7.1. Introduction
  • 7.2. Acute Care Facilities
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas Vascular Closure Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vascular Closure Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Vascular Closure Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Cardinal Health, Inc.
  • 3. Cardiva Medical, Inc.
  • 4. Cordis Corporation
  • 5. INVAMED
  • 6. Medtronic PLC
  • 7. Morris Innovative, Inc.
  • 8. Teleflex Incorporated
  • 9. Terumo Corporation
  • 10. Tricol Biomedical, Inc.
  • 11. TZ Medical, Inc
  • 12. Vasorum Ltd.
  • 13. Veryan Medical Ltd
  • 14. Vivasure Medical Ltd.
  • 15. W. L. Gore & Associates

LIST OF FIGURES

  • FIGURE 1. VASCULAR CLOSURE DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR CLOSURE DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR CLOSURE DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR CLOSURE DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL HEMOSTATIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COMPRESSION-ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT- OR GEL-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACUTE CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023